Log in to save to my catalogue

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interven...

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interven...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_39b34a94248e4ed6ae7e535283e338f7

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

About this item

Full title

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Patient preference and adherence, 2023-01, Vol.17, p.861-872

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

The status of dupilumab self-injection at home is not well understood. We therefore aimed to identify the barriers to adherence to dupilumab self-injection.
This non-interventional open-label study was conducted between March 2021 and July 2021. Patients with atopic dermatitis, bronchial asthma, and chronic rhinosinusitis with nasal polyps recei...

Alternative Titles

Full title

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_39b34a94248e4ed6ae7e535283e338f7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_39b34a94248e4ed6ae7e535283e338f7

Other Identifiers

ISSN

1177-889X

E-ISSN

1177-889X

DOI

10.2147/PPA.S389865

How to access this item